FOXO1 deficiency impairs proteostasis in aged T cells

Jun Jin,Xuanying Li,Bin Hu,Chulwoo Kim,Wenqiang Cao,Huimin Zhang,Cornelia M. Weyand,Jorg J. Goronzy

DOI: https://doi.org/10.1126/sciadv.aba1808

IF: 13.6

2020-04-24

Science Advances

Abstract:Impaired FOXO1 expression in CD4 T cell responses from old adults causes expanded multivesicular bodies sequestering GSK3β.

multidisciplinary sciences

What problem does this paper attempt to address?

FOXO1 constrains activation and regulates senescence in CD8 T cells

Arnaud Delpoux,Nimi Marcel,Rodrigo Hess Michelini,Carol D Katayama,Karmel A Allison,Christopher K Glass,Sergio M Quiñones-Parra,Cornelis Murre,Liyen Loh,Katherine Kedzierska,Martha Lappas,Stephen M Hedrick,Andrew L Doedens

DOI: https://doi.org/10.1016/j.celrep.2020.108674

2021-01-26

Abstract:Naive and memory T cells are maintained in a quiescent state, yet capable of rapid response and differentiation to antigen challenge via molecular mechanisms that are not fully understood. In naive cells, the deletion of Foxo1 following thymic development results in the increased expression of multiple AP-1 family members, rendering T cells less able to respond to antigenic challenge. Similarly, in the absence of FOXO1, post-infection memory T cells exhibit the characteristics of extended activation and senescence. Age-based analysis of human peripheral T cells reveals that levels of FOXO1 and its downstream target, TCF7, are inversely related to host age, whereas the opposite is found for AP-1 factors. These characteristics of aging also correlate with the formation of T cells manifesting features of cellular senescence. Our work illustrates a role for FOXO1 in the active maintenance of stem-like properties in T cells at the timescales of acute infection and organismal life span.
FoxO1 Is a Novel Regulator of 20S Proteasome Subunits Expression and Activity

Marianna Kapetanou,Tobias Nespital,Luke S Tain,Andre Pahl,Linda Partridge,Efstathios S Gonos

DOI: https://doi.org/10.3389/fcell.2021.625715

2021-02-05

Abstract:Proteostasis collapses during aging resulting, among other things, in the accumulation of damaged and aggregated proteins. The proteasome is the main cellular proteolytic system and plays a fundamental role in the maintenance of protein homeostasis. Our previous work has demonstrated that senescence and aging are related to a decline in proteasome content and activities, while its activation extends lifespan in vitro and in vivo in various species. However, the mechanisms underlying this age-related decline of proteasome function and the down-regulation in expression of its subunits remain largely unclear. Here, we demonstrate that the Forkhead box-O1 (FoxO1) transcription factor directly regulates the expression of a 20S proteasome catalytic subunit and, hence, proteasome activity. Specifically, we demonstrate that knockout of FoxO1, but not of FoxO3, in mice severely impairs proteasome activity in several tissues, while depletion of IRS1 enhances proteasome function. Importantly, we show that FoxO1 directly binds on the promoter region of the rate-limiting catalytic β5 proteasome subunit to regulate its expression. In summary, this study reveals the direct role of FoxO factors in the regulation of proteasome function and provides new insight into how FoxOs affect proteostasis and, in turn, longevity.
Type 1 interferons and Foxo1 down-regulation play a key role in age-related T-cell exhaustion in mice

Aurélie Durand,Nelly Bonilla,Théo Level,Zoé Ginestet,Amélie Lombès,Vincent Guichard,Mathieu Germain,Sébastien Jacques,Franck Letourneur,Marcio Do Cruzeiro,Carmen Marchiol,Gilles Renault,Morgane Le Gall,Céline Charvet,Agnès Le Bon,Bruno Martin,Cédric Auffray,Bruno Lucas

DOI: https://doi.org/10.1038/s41467-024-45984-8

IF: 16.6

2024-02-26

Nature Communications

Abstract:Abstract Foxo family transcription factors are critically involved in multiple processes, such as metabolism, quiescence, cell survival and cell differentiation. Although continuous, high activity of Foxo transcription factors extends the life span of some species, the involvement of Foxo proteins in mammalian aging remains to be determined. Here, we show that Foxo1 is down-regulated with age in mouse T cells. This down-regulation of Foxo1 in T cells may contribute to the disruption of naive T-cell homeostasis with age, leading to an increase in the number of memory T cells. Foxo1 down-regulation is also associated with the up-regulation of co-inhibitory receptors by memory T cells and exhaustion in aged mice. Using adoptive transfer experiments, we show that the age-dependent down-regulation of Foxo1 in T cells is mediated by T-cell-extrinsic cues, including type 1 interferons. Taken together, our data suggest that type 1 interferon-induced Foxo1 down-regulation is likely to contribute significantly to T-cell dysfunction in aged mice.

multidisciplinary sciences
FOXO1 differentially regulates bone formation in young and aged mice

Yi Xiong,Yixin Zhang,Feng Zhou,Yeyu Liu,Zumu Yi,Ping Gong,Yingying Wu

DOI: https://doi.org/10.1016/j.cellsig.2022.110438

Abstract:It is a great challenge to develop a safe and effective treatment strategy for age-related osteoporosis and fracture healing. As one of the four FOXO transcription factors, FOXO1 is essential for cell proliferation, survival, senescence, energy metabolism, and oxidative stress in various cells. Our previous study demonstrated that specific Foxo1 gene deletion in osteoblasts in young mice results in bone loss while that in aged mice shows the opposite effect. However, the mechanism underlying the differential regulation of bone metabolism by FOXO1 remains to be elucidated. In this study, we generated osteoblast-specific Foxo1 knockout mice by using Foxo1fl/fl and Bglap-Cre mice. In young mice, Foxo1 gene deletion inhibits osteoblast differentiation, leading to a decreased osteoblast number and decreased bone formation rate because of the weakened ability to resist oxidative stress, eventually resulting in bone loss and delayed healing of bone defects. In aged mice, high levels of reactive oxygen species (ROS) promote the diversion of CTNNB1 (β-catenin) from T cell factor 4 (TCF4)- to FOXO1-mediated transcription, thereby inhibiting Wnt/β-catenin signaling and leading to decreased osteogenic activity. Conversely, FOXO1 deficiency indirectly promotes the binding of β-catenin and TCF4 and activates Wnt/β-catenin signaling, thereby alleviating age-related bone loss and improving bone defect healing. Our study proves that FOXO1 has differential effects on bone metabolism in young and aged mice and elucidates its underlying mechanism. Further, this study provides a new perspective on the treatment of age-related osteoporosis.
FoxO transcription factors support oxidative stress resistance in human chondrocytes

Yukio Akasaki,Oscar Alvarez-Garcia,Masahiko Saito,Beatriz Caramés,Yukihide Iwamoto,Martin K Lotz

DOI: https://doi.org/10.1002/art.38868

Abstract:Objective: A major signaling pathway that regulates cellular aging is the insulin/insulin-like growth factor 1 (IGF-1)/phosphatidylinositol 3-kinase (PI3K)/Akt/FoxO transcription factor axis. We previously observed that FoxO transcription factors are dysregulated in aged and OA cartilage. The objective of this study was to investigate the impact of down-regulated FoxO transcription factors on chondrocytes. Methods: Small interfering RNAs (siRNAs) targeting FOXO1 (siFOXO1) and FOXO3 (siFOXO3) were transfected into human articular chondrocytes. Cell viability following treatment with the oxidant tert-butyl-hydroperoxide (tBHP) was measured by MTT assay. Caspase 3/7 activation and apoptotic cells were examined. Gene and protein expression of antioxidant proteins and autophagy-related proteins and changes in inflammatory mediators following treatment with interleukin-1β were assessed. Cells transfected with FOXO plasmids were also analyzed. Results: Cell viability was significantly reduced by siFOXO after treatment with tBHP. Apoptosis accompanied by caspase activation was significantly increased in siFOXO-transfected chondrocytes. Knockdown of FOXO1 and FOXO1+3 resulted in significant reductions in levels of glutathione peroxidase 1 (GPX-1), catalase, light chain 3 (LC3), Beclin1, and sirtuin 1 (SIRT-1) proteins following treatment with tBHP. In contrast, the constitutive active form of FOXO3 increased cell viability while inducing GPX-1, Beclin1, and LC3 in response to tBHP. Expression and production of ADAMTS-4 and chemerin were significantly increased in siFOXO-transfected chondrocytes. Conclusion: Reduced expression of FoxO transcription factors in chondrocytes increased susceptibility to cell death induced by oxidative stress. This was associated with reduced levels of antioxidant proteins and autophagy-related proteins. Our data provide evidence for a key role of FoxO transcription factors as regulators of chondrocyte oxidative stress resistance and tissue homeostasis.
Abstract 4910: Forkhead Transcription Factor 3a (foxo3a) is Involved in the Regulation of Functional Response to Aging and Stress in Murine Cardiomyocytes

Qun Li,Heng Ma,Paul Thomas,Machender R Kandadi,Jun Ren

DOI: https://doi.org/10.1161/circ.120.suppl_18.s1019-a

IF: 37.8

2009-01-01

Circulation

Abstract:Aging is a complicated but regulated process. Forkhead transcription factors (FOXO), the major substrates for the protein kinase Akt and AMP-activated protein kinase, play an important role in longevity. Our earlier studies suggested that deficiency in insulin-growth factor I (IGF-1) contribute to cardiomyocyte dysfunction but prolongs lifespan possibly through downregulation of FOXO3a signaling. Given that lifespan extension is closely associated with stress tolerance, our present study was set to examine the effect of FOXO3a inhibition on aging-/stress-induced cardiomyocyte contractility and survival. The dominant negative FOXO3a-GFP adenovirus was injected into adult and aged C57BL/6J murine hearts. Five days later, GFP positive cardiomyocytes (denoting successful Foxo3a transfection) isolated from in adult and old C57BL/6J mice were identified for assessment of contractile properties including peak shortening (PS), time-to-PS (TPS), time-to-relengthening (TR 90 ), and maximal velocity of shortening/relengthening (+/−dL/dt). Dominant negative FOXO3a (FDN) transfection significantly reduced PS in adult group although it restored aging-induced dysfunction in PS, +/−dL/dt and TR 90 . Further study on MTT assay and western blot revealed that transfection of FDN in H9c2 myoblasts exhibited higher survival rate in response to paraquat and H 2 O 2 compared to control group. Inhibition of FOXO3a expression enhanced phosphorylation of Akt and AMPK in both normal and paraquat-treated conditions. Paraquat downregulated the “aging” protein-klotho, the effect of which was restored by FDN transfection. These data suggested that FOXO3a plays an important role in regulation of cardiomyocyte contractility and stress resistance under aging or oxidative stress.
Suppression of FOXO1 attenuates inflamm‐aging and improves liver function during aging

Wanbao Yang,Da Mi Kim,Wen Jiang,Weiqi Ai,Quan Pan,Shahina Rahman,James J Cai,Wesley A Brashear,Yuxiang Sun,Shaodong Guo,James J. Cai,Wesley A. Brashear

DOI: https://doi.org/10.1111/acel.13968

IF: 11.005

2023-08-23

Aging Cell

Abstract:Aging activates hepatic FOXO signaling pathway, increases hepatic fat deposition, induces insulin resistance, stimulates pro‐inflammation in Kupffer cells (KCs), and leads to a functional quiescence of monocyte‐infiltrated macrophages (MDMs) in liver. Inhibition of FOXO1 decreases hepatic fat accumulation, improves insulin sensitivity, and attenuates pro‐inflammation in KCs during aging. The liver is a key metabolic organ that maintains whole‐body nutrient homeostasis. Aging‐induced liver function alterations contribute to systemic susceptibility to aging‐related diseases. However, the molecular mechanisms of liver aging remain insufficiently understood. In this study, we performed bulk RNA‐Seq and single‐cell RNA‐Seq analyses to investigate the underlying mechanisms of the aging‐induced liver function changes. We found that liver inflammation, glucose intolerance, and liver fat deposition were aggravated in old mice. Aging significantly increased pro‐inflammation in hepatic macrophages. Furthermore, we found that Kupffer cells (KCs) were the major driver to induce pro‐inflammation in hepatic macrophages during aging. In KCs, aging significantly increased pro‐inflammatory levels; in monocyte‐derived macrophages (MDMs), aging had a limited effect on pro‐inflammation but led to a functional quiescence in antigen presentation and phagosome process. In addition, we identified an aging‐responsive KC‐specific (ARKC) gene set that potentially mediates aging‐induced pro‐inflammation in KCs. Interestingly, FOXO1 activity was significantly increased in the liver of old mice. FOXO1 inhibition by AS1842856 significantly alleviated glucose intolerance, hepatic steatosis, and systemic inflammation in old mice. FOXO1 inhibition significantly attenuated aging‐induced pro‐inflammation in KCs partially through downregulation of ARKC genes. However, FOXO1 inhibition had a limited effect on aging‐induced functional quiescence in MDMs. These results indicate that aging induces pro‐inflammation in liver mainly through targeting KCs and FOXO1 is a key player in aging‐induced pro‐inflammation in KCs. Thus, FOXO1 could be a potential therapeutic target for the treatment of age‐associated chronic diseases.

cell biology,geriatrics & gerontology
Identification of FOXO1 as a geroprotector in human synovium through single-nucleus transcriptomic profiling

Feifei Liu,Yi Lu,Xuebao Wang,Shuhui Sun,Huize Pan,Min Wang,Zehua Wang,Weiqi Zhang,Shuai Ma,Guoqiang Sun,Qun Chu,Si Wang,Jing Qu,Guang-Hui Liu

DOI: https://doi.org/10.1093/procel/pwad060

2024-05-28

Abstract:The synovium, a thin layer of tissue that is adjacent to the joints and secretes synovial fluid, undergoes changes in aging that contribute to intense shoulder pain and other joint diseases. However, the mechanism underlying human synovial aging remains poorly characterized. Here, we generated a comprehensive transcriptomic profile of synovial cells present in the subacromial synovium from young and aged individuals. By delineating aging-related transcriptomic changes across different cell types and their associated regulatory networks, we identified two subsets of mesenchymal stromal cells (MSCs) in human synovium, which are lining and sublining MSCs, and found that angiogenesis and fibrosis-associated genes were upregulated whereas genes associated with cell adhesion and cartilage development were downregulated in aged MSCs. Moreover, the specific cell-cell communications in aged synovium mirrors that of aging-related inflammation and tissue remodeling, including vascular hyperplasia and tissue fibrosis. In particular, we identified forkhead box O1 (FOXO1) as one of the major regulons for aging differentially expressed genes (DEGs) in synovial MSCs, and validated its downregulation in both lining and sublining MSC populations of the aged synovium. In human FOXO1-depleted MSCs derived from human embryonic stem cells, we recapitulated the senescent phenotype observed in the subacromial synovium of aged donors. These data indicate an important role of FOXO1 in the regulation of human synovial aging. Overall, our study improves our understanding of synovial aging during joint degeneration, thereby informing the development of novel intervention strategies aimed at rejuvenating the aged joint.
Differential Dose- and Tissue-Dependent Effects of foxo on Aging, Metabolic and Proteostatic Pathways

Maria S Manola,Sentiljana Gumeni,Ioannis P Trougakos

DOI: https://doi.org/10.3390/cells10123577

IF: 6

2021-12-18

Cells

Abstract:Aging is the gradual deterioration of physiological functions that culminates in death. Several studies across a wide range of model organisms have revealed the involvement of FOXO (forkhead box, class O) transcription factors in orchestrating metabolic homeostasis, as well as in regulating longevity. To study possible dose- or tissue-dependent effects of sustained foxo overexpression, we utilized two different Drosophila transgenic lines expressing high and relatively low foxo levels and overexpressed foxo, either ubiquitously or in a tissue-specific manner. We found that ubiquitous foxo overexpression (OE) accelerated aging, induced the early onset of age-related phenotypes, increased sensitivity to thermal stress, and deregulated metabolic and proteostatic pathways; these phenotypes were more intense in transgenic flies expressing high levels of foxo. Interestingly, there is a defined dosage of foxo OE in muscles and cardiomyocytes that shifts energy resources into longevity pathways and thus ameliorates not only tissue but also organismal age-related defects. Further, we found that foxo OE stimulates in an Nrf2/cncC dependent-manner, counteracting proteostatic pathways, e.g., the ubiquitin-proteasome pathway, which is central in ameliorating the aberrant foxo OE-mediated toxicity. These findings highlight the differential dose- and tissue-dependent effects of foxo on aging, metabolic and proteostatic pathways, along with the foxo-Nrf2/cncC functional crosstalk.
Foxo3 Knockdown Mediates Decline of Myod1 and Myog Reducing Myoblast Conversion to Myotubes

Benjamin Gellhaus,Kai O Böker,Marlene Gsaenger,Eyck Rodenwaldt,Marc A Hüser,Arndt F Schilling,Dominik Saul

DOI: https://doi.org/10.3390/cells12172167

IF: 6

2023-08-29

Cells

Abstract:Sarcopenia has a high prevalence among the aging population. Sarcopenia is of tremendous socioeconomic importance because it can lead to falls and hospitalization, subsequently increasing healthcare costs while limiting quality of life. In sarcopenic muscle fibers, the E3 ubiquitin ligase F-Box Protein 32 (Fbxo32) is expressed at substantially higher levels, driving ubiquitin-proteasomal muscle protein degradation. As one of the key regulators of muscular equilibrium, the transcription factor Forkhead Box O3 (FOXO3) can increase the expression of Fbxo32, making it a possible target for the regulation of this detrimental pathway. To test this hypothesis, murine C2C12 myoblasts were transduced with AAVs carrying a plasmid for four specific siRNAs against Foxo3. Successfully transduced myoblasts were selected via FACS cell sorting to establish single clone cell lines. Sorted myoblasts were further differentiated into myotubes and stained for myosin heavy chain (MHC) by immunofluorescence. The resulting area was calculated. Myotube contractions were induced by electrical stimulation and quantified. We found an increased Foxo3 expression in satellite cells in human skeletal muscle and an age-related increase in Foxo3 expression in older mice in silico. We established an in vitro AAV-mediated FOXO3 knockdown on protein level. Surprisingly, the myotubes with FOXO3 knockdown displayed a smaller myotube size and a lower number of nuclei per myotube compared to the control myotubes (AAV-transduced with a functionless control plasmid). During differentiation, a lower level of FOXO3 reduced the expression Fbxo32 within the first three days. Moreover, the expression of Myod1 and Myog via ATM and Tp53 was reduced. Functionally, the Foxo3 knockdown myotubes showed a higher contraction duration and time to peak. Early Foxo3 knockdown seems to terminate the initiation of differentiation due to lack of Myod1 expression, and mediates the inhibition of Myog. Subsequently, the myotube size is reduced and the excitability to electrical stimulation is altered.
The rules and regulatory mechanisms of FOXO3 on inflammation, metabolism, cell death and aging in hosts

Guoding Cao,Monan Lin,Wei Gu,Zaiyu Su,Yagan Duan,Wuqi Song,Hailiang Liu,Fengmin Zhang

DOI: https://doi.org/10.1016/j.lfs.2023.121877

2023-09-01

Abstract:The FOX family of transcription factors was originally identified in 1989, comprising the FOXA to FOXS subfamilies. FOXO3, a well-known member of the FOXO subfamily, is widely expressed in various human organs and tissues, with higher expression levels in the ovary, skeletal muscle, heart, and spleen. The biological effects of FOXO3 are mostly determined by its phosphorylation, which occurs in the nucleus or cytoplasm. Phosphorylation of FOXO3 in the nucleus can promote its translocation into the cytoplasm and inhibit its transcriptional activity. In contrast, phosphorylation of FOXO3 in the cytoplasm leads to its translocation into the nucleus and exerts regulatory effects on biological processes, such as inflammation, aerobic glycolysis, autophagy, apoptosis, oxidative stress, cell cycle arrest and DNA damage repair. Additionally, FOXO3 isoform 2 acts as an important suppressor of osteoclast differentiation. FOXO3 can also interfere with the development of various diseases, including inhibiting the proliferation and invasion of tumor cells, blocking the production of inflammatory factors in autoimmune diseases, and inhibiting β-amyloid deposition in Alzheimer's disease. Furthermore, FOXO3 slows down the aging process and exerts anti-aging effects by delaying telomere attrition, promoting cell self-renewal, and maintaining genomic stability. This review suggests that changes in the levels and post-translational modifications of FOXO3 protein can maintain organismal homeostasis and improve age-related diseases, thus counteracting aging. Moreover, this may indicate that alterations in FOXO3 protein levels are also crucial for longevity, offering new perspectives for therapeutic strategies targeting FOXO3.
FoxO3 Regulates Mouse Bone Mesenchymal Stem Cell Fate and Bone-Fat Balance During Skeletal Aging.

Wei Yu,Min-Ji Tong,Guo-Hao Wu,Tian-Le Ma,Chuan-Dong Cai,Li-Peng Wang,Ying-Kai Zhang,Jin-Lun Gu,Zuo-Qin Yan

DOI: https://doi.org/10.1089/scd.2024.0055

2024-01-01

Stem Cells and Development

Abstract:Age-related osteoporosis is characterized by an imbalance between osteogenic and adipogenic differentiation in bone mesenchymal stem cells (BMSCs). Forkhead box O 3 (FoxO3) transcription factor is involved in lifespan and cell differentiation. In this study, we explore whether FoxO3 regulates age-related bone loss and marrow fat accumulation. The expression levels of FoxO3 in BMSCs during aging were detected in vivo and in vitro. To explore the role of FoxO3 in osteogenic and adipogenic differentiation, primary BMSCs were isolated from young and aged mice. FoxO3 expression was modulated by adenoviral vector transfection. The role of FoxO3 in bone-fat balance was evaluated by alizarin red S staining, oil red O staining, quantitative reverse transcription-polymerase chain reaction, Western blot, and histological analysis. Age-related bone loss and fat deposit are associated with downregulation of FoxO3. Overexpression of FoxO3 alleviated age-related bone loss and marrow fat accumulation in aged mice. Mechanistically, FoxO3 reduced adipogenesis and enhanced osteogenesis of BMSCs via downregulation of PPAR-gamma and Notch signaling, respectively. In conclusion, FoxO3 is an essential factor controlling the fate of BMSCs and is a potential target for the prevention of age-related osteoporosis.
Aging-associated HELIOS deficiency in naive CD4+ T cells alters chromatin remodeling and promotes effector cell responses

Huimin Zhang,Rohit R Jadhav,Wenqiang Cao,Isabel N Goronzy,Tuantuan V Zhao,Jun Jin,Shozo Ohtsuki,Zhaolan Hu,Jose Morales,William J Greenleaf,Cornelia M Weyand,Jörg J Goronzy

DOI: https://doi.org/10.1038/s41590-022-01369-x

Abstract:Immune aging combines cellular defects in adaptive immunity with the activation of pathways causing a low-inflammatory state. Here we examined the influence of age on the kinetic changes in the epigenomic and transcriptional landscape induced by T cell receptor (TCR) stimulation in naive CD4+ T cells. Despite attenuated TCR signaling in older adults, TCR activation accelerated remodeling of the epigenome and induced transcription factor networks favoring effector cell differentiation. We identified increased phosphorylation of STAT5, at least in part due to aberrant IL-2 receptor and lower HELIOS expression, as upstream regulators. Human HELIOS-deficient, naive CD4+ T cells, when transferred into human-synovium-mouse chimeras, infiltrated tissues more efficiently. Inhibition of IL-2 or STAT5 activity in T cell responses of older adults restored the epigenetic response pattern to the one seen in young adults. In summary, reduced HELIOS expression in non-regulatory naive CD4+ T cells in older adults directs T cell fate decisions toward inflammatory effector cells that infiltrate tissue.
DNA damage and senescence in osteoprogenitors expressing Osx1 may cause their decrease with age

Ha-Neui Kim,Jianhui Chang,Lijian Shao,Li Han,Srividhya Iyer,Stavros C Manolagas,Charles A O'Brien,Robert L Jilka,Daohong Zhou,Maria Almeida

DOI: https://doi.org/10.1111/acel.12597

IF: 11.005

Aging Cell

Abstract:Age-related bone loss in mice results from a decrease in bone formation and an increase in cortical bone resorption. The former is accounted by a decrease in the number of postmitotic osteoblasts which synthesize the bone matrix and is thought to be the consequence of age-dependent changes in mesenchymal osteoblast progenitors. However, there are no specific markers for these progenitors, and conclusions rely on results from in vitro cultures of mixed cell populations. Moreover, the culprits of such changes remain unknown. Here, we have used Osx1-Cre;TdRFP mice in which osteoprogenitors express the TdRFP fluorescent protein. We report that the number of TdRFP-Osx1 cells, freshly isolated from the bone marrow, declines by more than 50% between 6 and 24 months of age in both female and male mice. Moreover, TdRFP-Osx1 cells from old mice exhibited markers of DNA damage and senescence, such as γH2AX foci, G1 cell cycle arrest, phosphorylation of p53, increased p21CIP1 levels, as well as increased levels of GATA4 and activation of NF-κB - two major stimulators of the senescence-associated secretory phenotype (SASP). Bone marrow stromal cells from old mice also exhibited elevated expression of SASP genes, including several pro-osteoclastogenic cytokines, and increased capacity to support osteoclast formation. These changes were greatly attenuated by the senolytic drug ABT263. Together, these findings suggest that the decline in bone mass with age is the result of intrinsic defects in osteoprogenitor cells, leading to decreased osteoblast numbers and increased support of osteoclast formation.
FOXO1 and ETV6 genes may represent novel regulators of splicing factor expression in cellular senescence

Eva Latorre,Elizabeth L Ostler,Richard G A Faragher,Lorna W Harries

DOI: https://doi.org/10.1096/fj.201801154R

Abstract:Cellular plasticity is a key facet of cellular homeostasis requiring correct temporal and spatial patterns of alternative splicing. Splicing factors, which orchestrate this process, demonstrate age-related dysregulation of expression; they are emerging as potential influences on aging and longevity. The upstream drivers of these alterations are still unclear but may involve aberrant cellular signaling. We compared the phosphorylation status of proteins in multiple signaling pathways in early and late passage human primary fibroblasts. We then assessed the impact of chemical inhibition or targeted knockdown of direct downstream targets of the ERK and AKT pathways on splicing factor expression, cellular senescence, and proliferation kinetics in senescent primary human fibroblasts. Components of the ERK and AKT signaling pathways demonstrated altered activation during cellular aging. Inhibition of AKT and ERK pathways led to up-regulation of splicing factor expression, reduction in senescent cell load, and partial reversal of multiple cellular senescence phenotypes in a dose-dependent manner. Furthermore, targeted knockdown of the genes encoding the downstream targets FOXO1 or ETV6 was sufficient to mimic these observations. Our results suggest that age-associated dysregulation of splicing factor expression and cellular senescence may derive in part from altered activity of ERK and AKT signaling and may act in part through the ETV6 and FOXO1 transcription factors. Targeting the activity of downstream effectors of ERK and AKT may therefore represent promising targets for future therapeutic intervention.-Latorre, E., Ostler, E. L., Faragher, R. G. A., Harries, L. W. FOXO1 and ETV6 genes may represent novel regulators of splicing factor expression in cellular senescence.
Autophagy Deficiency Leads to Impaired Antioxidant Defense Via P62-Foxo1/3 Axis

Lin Zhao,Hao Li,Yan Wang,Adi Zheng,Liu Cao,Jiankang Liu

DOI: https://doi.org/10.1155/2019/2526314

2019-01-01

Oxidative Medicine and Cellular Longevity

Abstract:Autophagy, an intracellular degradation mechanism eliminating unused or damaged cytoplasmic components for recycling, is often activated in response to diverse types of stress, profoundly influencing cellular physiology or pathophysiology. Upon encountering oxidative stress, autophagy acts rapidly and effectively to remove oxidized proteins or organelles, including damaged mitochondria that generate more ROS, thereby indirectly contributing to the maintenance of redox homeostasis. Emerging studies are shedding light on the crosstalks among autophagy, mitochondria, and oxidative stress; however, whether and how autophagy could directly modulate antioxidant defense and redox homeostasis remains unaddressed. Here, we showed mitochondrial dysfunction, elevated ROS level, impaired antioxidant enzymes, and loss of FOXO1/3 in autophagy deficiency cellular models established by either chemical inhibitors or knocking down/out key molecules implementing autophagy, and overexpression of FOXO1/3 restored antioxidant enzymes hence suppressed elevated ROS; knockdown of p62 increased protein level of FOXO1/3 and recovered FOXO1 in Atg5-knockdown cells. Our data demonstrates that the loss of FOXO1/3 is responsible for the impairment of antioxidant enzymes and the consequent elevation of ROS, and accumulation of p62 under condition of autophagy deficiency might be mediating the loss of FOXO1/3. Furthermore, we found in an animal model that the p62-FOXO1/3 axis could be dominant in aging liver but not in type 2 diabetic liver. Together, these evidences uncover the p62-FOXO1/3 axis as the molecular cue that underlies the impairment of antioxidant defense in autophagy deficiency and suggest its potential involvement in aging, substantiating the impact of inadequate autophagy on mitochondria and redox homeostasis.
Activation of mTORC1 at late endosomes misdirects T cell fate decision in older individuals

Jun Jin,Chulwoo Kim,Qiong Xia,Timothy M Gould,Wenqiang Cao,Huimin Zhang,Xuanying Li,Daniela Weiskopf,Alba Grifoni,Alessandro Sette,Cornelia M Weyand,Jorg J Goronzy

DOI: https://doi.org/10.1126/sciimmunol.abg0791

2021-06-18

Abstract:The nutrient-sensing mammalian target of rapamycin (mTOR) is integral to cell fate decisions after T cell activation. Sustained mTORC1 activity favors the generation of terminally differentiated effector T cells instead of follicular helper and memory T cells. This is particularly pertinent for T cell responses of older adults who have sustained mTORC1 activation despite dysfunctional lysosomes. Here, we show that lysosome-deficient T cells rely on late endosomes rather than lysosomes as an mTORC1 activation platform, where mTORC1 is activated by sensing cytosolic amino acids. T cells from older adults have an increased expression of the plasma membrane leucine transporter SLC7A5 to provide a cytosolic amino acid source. Hence, SLC7A5 and VPS39 deficiency (a member of the HOPS complex promoting early to late endosome conversion) substantially reduced mTORC1 activities in T cells from older but not young individuals. Late endosomal mTORC1 is independent of the negative-feedback loop involving mTORC1-induced inactivation of the transcription factor TFEB that controls expression of lysosomal genes. The resulting sustained mTORC1 activation impaired lysosome function and prevented lysosomal degradation of PD-1 in CD4+ T cells from older adults, thereby inhibiting their proliferative responses. VPS39 silencing of human T cells improved their expansion to pertussis and to SARS-CoV-2 peptides in vitro. Furthermore, adoptive transfer of CD4+ Vps39-deficient LCMV-specific SMARTA cells improved germinal center responses, CD8+ memory T cell generation, and recall responses to infection. Thus, curtailing late endosomal mTORC1 activity is a promising strategy to enhance T cell immunity.
Recombinant FOXN1 fusion protein increases T cell generation in old mice

Jin Zhao,Rong Hu,Kuan Chen Lai,Zhenzhen Zhang,Laijun Lai

DOI: https://doi.org/10.3389/fimmu.2024.1423488

IF: 7.3

2024-07-13

Frontiers in Immunology

Abstract:T cell development in the thymus is dependent on the thymic microenvironment, in which thymic epithelial cells (TECs) are the major component. However, TECs undergo both a qualitative and quantitative loss during aging, which is believed to be the major factor responsible for age-dependent thymic atrophy. FOXN1 plays a critical role in TEC development and adult TECs maintenance. We have previously reported that intrathymic injection of a recombinant (r) protein containing murine FOXN1 and a protein transduction domain increases the number of TECs in mice, leading to enhanced thymopoiesis. However, intrathymic injection may not be an ideal choice for clinical applications. In this study, we produced a rFOXN1 fusion protein containing the N-terminal of CCR9, human FOXN1 and a protein transduction domain. When injected intravenously into 14-month-old mice, the rFOXN1 fusion protein enters the thymus and TECs, and enhances thymopoiesis, resulting in increased T cell generation in the thymus and increased number of T cells in peripheral lymphoid organ. Our results suggest that the rFOXN1 fusion protein has the potential to be used in preventing and treating T cell immunodeficiency in older adults.

immunology
Recombinant FOXN1 fusion protein increases T cell generation in aged mice

Kuan-Chen Lai,Zhenzhen Zhang,Laijun Lai,Jin Zhao

DOI: https://doi.org/10.21203/rs.3.rs-2557067/v1

2023-02-08

Abstract:Background: Although the thymus continues to export T cells throughout life, it undergoes a profound involution/atrophy with age, resulting in decreased numbers of T cells in the older adult, which has direct etiological linkages with many diseases. T cell development in the thymus is dependent on the thymic microenvironment, in which thymic epithelial cells (TECs) are the major component. However, TECs undergo both a qualitative and quantitative loss during aging, which is believed to be the major factor responsible for age-dependent thymic atrophy. FOXN1 plays a critical role in TEC development and adult TECs maintenance. We have previously reported that intrathymic injection of a recombinant (r) protein containing FOXN1 and a protein transduction domain increases the number of TECs in mice, leading to enhanced thymopoiesis. However, intrathymic injection may not be an ideal choice for clinical applications. In this study, we produce a rFOXN1 fusion protein containing the N-terminal of CCR9, FOXN1 and a protein transduction domain. Results: We show here that, when injected intravenously into aged mice, the rFOXN1 fusion protein migrates into the thymus and enhances thymopoiesis, resulting in increased T cell generation in the thymus and increased number of T cells in peripheral lymphoid organ. Conclusions: Our results suggest that the rFOXN1 fusion protein has the potential to be used in preventing and treating T cell immunodeficiency in the older adult.

Biology,Medicine
Dysregulation of DAF-16/FOXO3A-mediated stress responses accelerates oxidative DNA damage induced aging

Aditi U Gurkar,Andria R Robinson,Yuxiang Cui,Xuesen Li,Shailaja K Allani,Amanda Webster,Mariya Muravia,Mohammad Fallahi,Herbert Weissbach,Paul D Robbins,Yinsheng Wang,Eric E Kelley,Claudette M St Croix,Laura J Niedernhofer,Matthew S Gill

DOI: https://doi.org/10.1016/j.redox.2018.06.005

Abstract:DNA damage is presumed to be one type of stochastic macromolecular damage that contributes to aging, yet little is known about the precise mechanism by which DNA damage drives aging. Here, we attempt to address this gap in knowledge using DNA repair-deficient C. elegans and mice. ERCC1-XPF is a nuclear endonuclease required for genomic stability and loss of ERCC1 in humans and mice accelerates the incidence of age-related pathologies. Like mice, ercc-1 worms are UV sensitive, shorter lived, display premature functional decline and they accumulate spontaneous oxidative DNA lesions (cyclopurines) more rapidly than wild-type worms. We found that ercc-1 worms displayed early activation of DAF-16 relative to wild-type worms, which conferred resistance to multiple stressors and was important for maximal longevity of the mutant worms. However, DAF-16 activity was not maintained over the lifespan of ercc-1 animals and this decline in DAF-16 activation corresponded with a loss of stress resistance, a rise in oxidant levels and increased morbidity, all of which were cep-1/ p53 dependent. A similar early activation of FOXO3A (the mammalian homolog of DAF-16), with increased resistance to oxidative stress, followed by a decline in FOXO3A activity and an increase in oxidant abundance was observed in Ercc1-/- primary mouse embryonic fibroblasts. Likewise, in vivo, ERCC1-deficient mice had transient activation of FOXO3A in early adulthood as did middle-aged wild-type mice, followed by a late life decline. The healthspan and mean lifespan of ERCC1 deficient mice was rescued by inactivation of p53. These data indicate that activation of DAF-16/FOXO3A is a highly conserved response to genotoxic stress that is important for suppressing consequent oxidative stress. Correspondingly, dysregulation of DAF-16/FOXO3A appears to underpin shortened healthspan and lifespan, rather than the increased DNA damage burden itself.

FOXO1 deficiency impairs proteostasis in aged T cells

FOXO1 constrains activation and regulates senescence in CD8 T cells

FoxO1 Is a Novel Regulator of 20S Proteasome Subunits Expression and Activity

Type 1 interferons and Foxo1 down-regulation play a key role in age-related T-cell exhaustion in mice

FOXO1 differentially regulates bone formation in young and aged mice

FoxO transcription factors support oxidative stress resistance in human chondrocytes

Abstract 4910: Forkhead Transcription Factor 3a (foxo3a) is Involved in the Regulation of Functional Response to Aging and Stress in Murine Cardiomyocytes

Suppression of FOXO1 attenuates inflamm‐aging and improves liver function during aging

Identification of FOXO1 as a geroprotector in human synovium through single-nucleus transcriptomic profiling

Differential Dose- and Tissue-Dependent Effects of foxo on Aging, Metabolic and Proteostatic Pathways

Foxo3 Knockdown Mediates Decline of Myod1 and Myog Reducing Myoblast Conversion to Myotubes

The rules and regulatory mechanisms of FOXO3 on inflammation, metabolism, cell death and aging in hosts

FoxO3 Regulates Mouse Bone Mesenchymal Stem Cell Fate and Bone-Fat Balance During Skeletal Aging.

Aging-associated HELIOS deficiency in naive CD4+ T cells alters chromatin remodeling and promotes effector cell responses

DNA damage and senescence in osteoprogenitors expressing Osx1 may cause their decrease with age

FOXO1 and ETV6 genes may represent novel regulators of splicing factor expression in cellular senescence

Autophagy Deficiency Leads to Impaired Antioxidant Defense Via P62-Foxo1/3 Axis

Activation of mTORC1 at late endosomes misdirects T cell fate decision in older individuals

Recombinant FOXN1 fusion protein increases T cell generation in old mice

Recombinant FOXN1 fusion protein increases T cell generation in aged mice

Dysregulation of DAF-16/FOXO3A-mediated stress responses accelerates oxidative DNA damage induced aging